Transgene Biotek Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
2.16 +0.06 (2.84%)Updated : 11 Feb 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net 1.02-0.000.00
Net Changein Cash 0.280.00-0.010.00
Cash Taxes Paid 0.00---
Net Income/ Starting Line -0.68-0.66-6.01-10.40
Changesin Working Capital 1.720.611.050.52
Cashfrom Operating Activities 1.200.000.000.10
Cash Interest Paid 0.24---
Cashfrom Financing Activities 0.780.000.000.00
Depreciation/ Depletion 0.090.094.959.92
Other Investing Cash Flow Items Total -1.700.000.00-0.10
Capital Expenditures 0.000.00-0.010.00
period Type ----
Non- Cash Items 0.06-0.050.010.05
Financing Cash Flow Items -0.240.00--
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -1.700.00-0.01-0.10
*All figures in crores except per share values
Recommended For You
Trending Stocks
305.75+16.90(5.85%)
207.50+5.40(2.67%)
367.50+5.65(1.56%)
1,577.70-24.35 (-1.52%)
968.35-14.65 (-1.49%)